Explore how AI-based image analysis can help you innovate faster in precision medicine!
Precision Medicine is already happening, and Artificial Intelligence opens whole new possibilities for in-depth exploration and quantification of anatomical lung structures, disease-related pathologies, treatment effect and mechanism of action.
With more than 20 years of research background and a proven track record in powering innovations in pharmaceutical drug development and interventional medicine, we understand how to use quantitative lung CT image analysis to its best potential.
From exploratory studies to large multi-center or longitudinal clinical trials, our analysis deliver advanced insights into common and rare pulmonary diseases, with consistently robust and reproducible results.
Join the daily LungQ lunch demos at our booth
Every day at 12:30 pm, 20-min demonstration by Thirona experts on our most advanced capabilities with AI-based image analysis
Sunday, 10 September: New treatment potential for pulmonary vascular diseases
Monday, 11 September: Pre-operative and intra-operative image analysis for bronchoscopic and surgical lung interventions
Tuesday, 12 September: Airway segmentation and quantification for emerging therapies in treatment of airway disease
Eva van Rikxoort, PhD
CEO & Founder
Jean-Paul Charbonnier, PhD
Chief Innovation Officer
Prof. Harm Tiddens, PhD
Chief Medical Officer
Walter van Kuijen
Chief Commercial Officer
Leticia Gallardo Estrella, PhD
Lead Deep Learning Engineer
Sanaz Berahmani, PhD
Business Development Manager
Carla Kalkhoven
Customer Success Manager
Karan Malhotra
Senior Deep Learning Engineer
Michail Tsiaousis
Senior Deep Learning Engineer
Abstract presentations of clinical validation studies with Thirona's LungQ™ analysis:
